
The new study included 468 women and 354 men with similar levels of insulin resistance. Among those aged 50 or younger, women had lower blood pressure, lower fasting blood sugar levels, and lower levels of fats in the blood (triglycerides) that can increase the risk of heart disease and stroke. However, these differences
zoloft and alcohol between women and men were not seen in participants aged 51 or older, according to the study published Sept. 24 in the Journal of Clinical Endocrinology & Metabolism. "This gender difference may illuminate the 'female advantage' -- a phenomenon where the onset of cardiovascular disease tends to happen a decade later in women than in men," study lead author Dr. Sun Kim, of Stanford University School of Medicine, said in a news release from the Endocrine Society.
More information about this article, visit
http://news.healingwell.com/index.php?p=news1&id=680417